(Q33193071)
Statements
CpG-A and B oligodeoxynucleotides enhance the efficacy of antibody therapy by activating different effector cell populations (English)
Lisette Bevaart
Annie Bakker
Heidi H. van Ojik
Christopher E. Dahle
Marco J. H. Jansen
Martine J. van Vugt
Jan G. J. van de Winkel
1 September 2003